India to Dominican Republic: Insulin Export Trade Route

The India to Dominican Republic Insulin corridor is one of India's established pharmaceutical export routes, with 16 shipments documented worth a combined $1.3M USD. The route is dominated by M. J. BIOPHARM PRIVATE LIMITED, which alone accounts for roughly 80% of all export value, reflecting the consolidated nature of India's insulin manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $80.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with insulin's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 10.6%, placing it at rank #12 among India's top insulin export destinations globally.

On the import side, key buyers of Indian insulin in Dominican Republic include DIABETIKA SRL. DIABETIKA SRL is the single largest importer with 16 shipments valued at $1.3M USD.

India's insulin exports to Dominican Republic are driven primarily by a handful of large-scale manufacturers. M. J. BIOPHARM PRIVATE LIMITED with 13 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Dominican Republic benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — M. J. BIOPHARM PRIVATE LIMITED, M J BIOPHARM PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $80.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as biosulin 30/70 insulin injection biphasi and biosulin 70/30 insulin injection biphasic isophane ph.eur.100 iu/ml,10 ml[humaninsulin injection 100 iu/ml,10 ml vials], suggesting that buyers in Dominican Republic tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, DIABETIKA SRL is the largest importer with 16 shipments worth $1.3M USD — representing 100% of all insulin imports from India on this route.